# Junta clínica — PT-pseudo_a2ed5cd06259 (tarea 1)

## Intervención 1 — INTAKE

*the record clerk; reads the file out loud and interprets nothing* · vuelta 1

Colleagues, this is the record as it arrived, field by field. I read it out and interpret nothing; everything after this is yours.

{
  "case_id": "PT-pseudo_a2ed5cd06259",
  "pid": "PT-pseudo_a2ed5cd06259",
  "task": 1,
  "psa": 4.6,
  "age": 76,
  "months": 3,
  "pirads": "5",
  "psad": 0.153,
  "psav": 0.81,
  "psap": 3.4,
  "vol": 30.02,
  "dre": "Normal",
  "bx": "Positive",
  "cspca": 0.8208632,
  "medhx": "Type 2 diabetes",
  "meds": "empagliflozin",
  "notes": "PSA 4.6 ng/mL. PI-RADS 5. PSAD 0.15. Prostate volume 30 mL. csPCa 0.82.",
  "pmhx": [
    "Type 2 diabetes"
  ],
  "allergies": [],
  "vitals": {
    "weight": "103 kg",
    "height": "193 cm",
    "bmi": "27.7",
    "bp": "137/83 mmHg",
    "hr": "65 bpm",
    "smoking": "Non-smoker",
    "last_dental": "3 yr ago",
    "flu_vax": "Oct 2024"
  },
  "enc_dept": "Urology - outpatient",
  "enc_date": "10 Jan 2025",
  "enc_ref": "Dr. T. Hendriks (GP)",
  "enc_type": "Re-evaluation - prior PCa diagnosis",
  "note_sections": [
    {
      "s": "Chief complaint",
      "t": "Ascending PSA values combined with a previously positive biopsy require specialist re-evaluation."
    },
    {
      "s": "History",
      "t": "A 76-year-old non-smoker initially entered evaluation due to a late-2023 PSA elevation. Later, a systematic biopsy confirmed low-grade disease. Type 2 diabetes is managed using empagliflozin. An IPSS score of 2 points to negligible urinary symptom bother. Formerly a police officer, he is divorced and resides with his partner. Weekends feature hiking trips. Alcohol remains capped at 13 units weekly. Orthopaedic follow-ups address a chronic knee issue. Podiatry visits handle foot maintenance. An Arabic interpreter has been requested. Bone pain, haematuria, and unexplained weight loss are denied. Overall wellness stays steady."
    },
    {
      "s": "Physical examination",
      "t": "DRE: Texture is uniformly smooth. Dimensions are symmetric. No nodularity. No asymmetry. General inspection shows a well-nourished individual appearing comfortable. Vital signs remain stable. Cardiopulmonary assessment is normal."
    }
  ],
  "occupation": "retired police officer",
  "marital": "Divorced",
  "living": "Lives with partner",
  "next_of_kin": "Spouse / partner (primary contact)",
  "recent_other": [
    "Orthopaedic outpatient — knee follow-up",
    "Podiatry — routine foot care"
  ],
  "alcohol": "13 units / week",
  "exercise": "Hiking on weekends",
  "ipss": "IPSS score: 2/35 (mild LUTS)",
  "admin": "Interpreter (Arabic) requested for next visit.",
  "mri_hospital": "Amsterdam UMC (location AMC)",
  "ct": null,
  "active_treatment_flag": 0
}

## Intervención 2 — INTAKE

*the record clerk; reads the file out loud and interprets nothing* · vuelta 1

And this is the same record as the reading form presents it — the panel the urologist sees up front, with the masked documents named but not shown.

You are a senior urologist reviewing a patient case. The structured clinical
record below is shown to you up front, exactly as in the reading form. Some
documents are not shown and must be pulled up via the available tools
(radiology / MRI report, pathology report, previous notes, laboratory
results, PSA history, and the family-history anamnesis) when you need to
consult them.

Case ID: PT-pseudo_a2ed5cd06259
Task: 1

Encounter: Urology - outpatient on 10 Jan 2025.
Referrer: Dr. T. Hendriks (GP).
Type: Re-evaluation - prior PCa diagnosis.

Clinical data (read-only — values loaded from the record):
  - 76-year-old male
  - PSA: 4.6 ng/mL
  - mpMRI — PI-RADS score: 5 (1–2 low · 3 equivocal · 4–5 high risk)
  - PSA density: 0.153 ng/mL²
  - PSA velocity: 0.81 ng/mL/yr
  - Prior PSA: 3.4 ng/mL
  - Prostate volume: 30.02 mL
  - Months since last PSA: 3
  - DRE findings: Normal (Normal · Nodus · Benign · Suspicious · Abnormal · Negative · Not done)
  - Prior biopsy: Positive (None · Negative · ASAP/HGPIN · Positive)
  - csPCa predicted probability: 0.8208632 (clinically significant PCa = ISUP ≥ 2)

Medical history & medication:
  - Medical history: Type 2 diabetes
  - Problem list / PMHx: Type 2 diabetes
  - Current medication: empagliflozin
  - Allergies: NKA
  - Additional notes: PSA 4.6 ng/mL. PI-RADS 5. PSAD 0.15. Prostate volume 30 mL. csPCa 0.82.

Vitals: weight 103 kg, height 193 cm, BMI 27.7, BP 137/83 mmHg, HR 65 bpm. Smoking: Non-smoker.

Chief complaint: Ascending PSA values combined with a previously positive biopsy require specialist re-evaluation.

History: A 76-year-old non-smoker initially entered evaluation due to a late-2023 PSA elevation. Later, a systematic biopsy confirmed low-grade disease. Type 2 diabetes is managed using empagliflozin. An IPSS score of 2 points to negligible urinary symptom bother. Formerly a police officer, he is divorced and resides with his partner. Weekends feature hiking trips. Alcohol remains capped at 13 units weekly. Orthopaedic follow-ups address a chronic knee issue. Podiatry visits handle foot maintenance. An Arabic interpreter has been requested. Bone pain, haematuria, and unexplained weight loss are denied. Overall wellness stays steady.

Physical examination: DRE: Texture is uniformly smooth. Dimensions are symmetric. No nodularity. No asymmetry. General inspection shows a well-nourished individual appearing comfortable. Vital signs remain stable. Cardiopulmonary assessment is normal.

Patient info: retired police officer; Divorced; Lives with partner.
Next of kin: Spouse / partner (primary contact).

Lifestyle: alcohol 13 units / week; exercise Hiking on weekends; IPSS score: 2/35 (mild LUTS).

Recent other appointments: Orthopaedic outpatient — knee follow-up; Podiatry — routine foot care.
Admin: Interpreter (Arabic) requested for next visit.

Information you can request via tools (the masked "Extended EHR view" — what
the urologist would actively pull up during the consult):
  - radiology / MRI report (full mpMRI prose behind the headline imaging values)
  - pathology report (any prior biopsy on record)
  - previous GP / urology consultation notes
  - laboratory results (full panel)
  - PSA history (trend / velocity beyond the headline value)
  - family history of prostate cancer (anamnesis)

Question:
Based on this patient's data, do you recommend biopsy?


One correction to that last paragraph before anybody acts on it: the documents this task actually serves are radiology_report, psa_trend, previous_notes, laboratory_results, plus the family-history anamnesis. There is NO pathology report to pull up in a task-1 biopsy decision — the prior-biopsy status on the panel above is all the pathology on record, and whatever the previous notes say about it. Nobody should ask for one, and nobody should quote one.

## Intervención 3 — EXPERT-STRUCTURED

*Expert 1, Extra-Trees on the structured panel only; opening bid with an error bar* · vuelta 1

Expert 1 here — the classifier that reads the structured panel and nothing else. My bid:

SUGGESTION: BIOPSY   p(biopsy) = 0.57
  uncertainty  +/- 0.10 epistemic (95% band 0.37-0.76); among patients I cannot tell apart the outcome was 0.99 of 1.00 mixed
  reliability  LOW ('discuss' tier) — out-of-fold it was right 55% of the time over the 38 labelled cases in this tier

VARIABLES I WEIGHED — in the form's vocabulary, with this man's values (panel only; the levels are what moved my prediction across the series, not what a urologist would mark)
  decisive   prior biopsy = Positive (43% of my signal; from bx_positive, bx_none)
  important  comorbidity = 1 on the problem list (21% of my signal; from pmhx_hypercholesterolaemia, n_comorbidities)
  noted      age = 76 (2% of my signal; from age) · DRE = Normal (10% of my signal; from dre_suspicious) · PSA = 4.6 ng/mL (3% of my signal; from log_psa, psav) · prostate volume = 30.02 mL (1% of my signal; from log_vol, vol) · PSA density = 0.153 (0% of my signal; from psad_calc, log_psad) · csPCa probability = 0.82 (1% of my signal; from cspca) · PI-RADS = 5 (20% of my signal; from pirads_ge4, pirads_ge3)
  not used   family history
CONFIDENCE: uncertain — 'discuss' tier; out-of-fold it was right 55% of the time over the 38 labelled cases in this tier

I read 39 raw variables, all from the panel — nothing from the mpMRI prose, the PSA
trajectory, the previous notes or the laboratory. Out-of-fold over 91 labelled cases: AUC
0.758, balanced accuracy 0.625.
The final call is the chair's.

## Intervención 4 — EXPERT-COHORT

*cohort criterion; what the labelled series did in this exact situation* · vuelta 1

This patient's situation: prior positive biopsy. The panel alone does not answer, and that is the finding.

The criterion here is that the visible panel does not determine this decision: he already has a tissue diagnosis, so neither a high PI-RADS nor a rising PSA is new information. What decides it is the documented grade of the prior biopsy and the surveillance history, which live in the previous notes. Measured on the labelled series: none of the three panel
rules I carry for this situation (PSA >= 20, age >= 78, PI-RADS <= 2) applies to him, and among the
39 remaining labelled men in this situation no structured variable separates the two answers.

REGISTRAR: the previous notes are where this case is decided. Read them for the grade of the prior
biopsy (Gleason or ISUP), the number of biopsy sessions and their dates, and whether he is on a
surveillance protocol with a confirmatory biopsy due. Do not read this as 'defer' and do not read it
as 'biopsy'.

VARIABLES I WEIGHED — in the form's vocabulary, with this man's values (panel only; 'decisive' marks the variable the rule turns on)
  important  prior biopsy = Positive
  noted      age = 76 · DRE = Normal · PSA = 4.6 ng/mL · prostate volume = 30.02 mL · PSA density = 0.153 · PI-RADS = 5 · comorbidity = 1 on the problem list
  not used   family history, csPCa probability
CONFIDENCE: uncertain — none of my three panel rules applies; the fact that would settle it — the documented prior grade — lives in the notes, not on the panel

## Intervención 5 — EXPERT-LIBRARY

*case library; the closest labelled precedents and what the reading urologist did with them* · vuelta 1

The case library holds 49 labelled men in this same situation (Positive prior biopsy). The 3 closest by panel distance, and what the reading urologist did:
  1. distance 0.94: PI-RADS 5, PSA 5.5, PSAD 0.12, age 71, DRE Normal -> BIOPSY (clear). He wrote: "Prev biopsy finding is left lobe, MRI finding highly suspicious of ISUP≥2 on right side. Active surveillance, only 1 biopsy session performed (of unclear date and unclea…"
  2. distance 1.15: PI-RADS 5, PSA 10.0, PSAD 0.27, age 75, DRE Normal -> BIOPSY (clear). He wrote: "New(? -> no old MRI report included) PIRADS 5 and rising PSA makes biopsy necessary"
  3. distance 1.31: PI-RADS 5, PSA 10.0, PSAD 0.372, age 75, DRE Normal -> BIOPSY (clear). He wrote: "Intermediate risk disease in 75yr with some comorbidity. No targeted biopsy and unclear timing (when was diagnosis and prev biopsy). Unclear if PIRADS5 was biopsied (lim…"

PRECEDENT: BIOPSY (weighted vote 1.00 for biopsy). Distance-weighted precedent is no better than chance here (0.47 leave-one-out): read the precedents for how this urologist reasons, not for the answer.

What the precedents are FOR: they show what this urologist looks at and how he phrases the call. What they are NOT: facts about this patient. Nobody may cite a precedent's grade, PSA or MRI as if it were his.

WHAT THE READING UROLOGIST WEIGHED IN THESE PRECEDENTS — in the form's vocabulary, with this man's values (weighted majority of the 3 nearest labelled traces; the distance itself is on PI-RADS, prior biopsy first)
  decisive   PI-RADS = 5
  important  prior biopsy = Positive · age = 76 · PSA = 4.6 ng/mL · csPCa probability = 0.82
  noted      family history = not opened (0 of 91) · DRE = Normal · prostate volume = 30.02 mL · PSA density = 0.153 · comorbidity = 1 on the problem list
CONFIDENCE: uncertain — in this situation the library is no better than chance (47% out of fold)

## Intervención 6 — EXPERT-TRACE

*Expert 4, trace model; which documents the reading urologist opens and what he weighs in this situation* · vuelta 1

Expert 4 here — the model of how the reading urologist works a case like this. Predicted from his 49 labelled traces in this situation (Positive prior biopsy): a per-field model where it beats the mode out of fold (prior-biopsy weight, DRE weight, PI-RADS weight, and whether he opens the laboratory), the mode elsewhere.

WHAT HE OPENS: radiology_report, psa_trend, previous_notes, laboratory_results.

WHAT HE WEIGHS — in the form's vocabulary, with this man's values (these are the levels that go on the form, unless a colleague shows a reason to move one)
  important  prior biopsy = Positive · age = 76 · PSA = 4.6 ng/mL · PI-RADS = 5
  noted      family history = not opened (0 of 91) · DRE = Normal · prostate volume = 30.02 mL · PSA density = 0.153 · comorbidity = 1 on the problem list
  not used   csPCa probability
CONFIDENCE: clear — the level the reading urologist records in this situation, from his labelled traces

MODERATOR: that list of documents is the plan — exactly those, no more. Every document opened beyond what
he would open is scored against the conference as an unnecessary reveal; every document left closed
leaves a variable he weighed without its source. Attach the question each one must answer.

## Intervención 7 — EXPERT-EAU

*EAU guideline specialist; speaks only from the guideline text he retrieved* · vuelta 1

GUIDELINE
"linking PI-RADS score (1-2, 3, and 4-5) to PSA-D categories (< 0.10, 0.10-0.15, 0.15-0.20 and > 0.20ng/mL) (Table 5.5) [230]. This risk-adapted matrix table may guide the decision to perform a biopsy."
The guideline suggests using the PI-RADS score and PSA density in conjunction with PSA-D categories to guide the decision to perform a biopsy. For this patient, the guideline requires establishing if the combination of PI-RADS 5 and PSA density of 0.153 falls into a category that mandates a biopsy.

WHAT THE EXPERTS' BIDS DO NOT SETTLE
EXPERT-STRUCTURED, I note that the guideline treats the PSA density as a factor in the risk-adapted matrix table. EXPERT-COHORT marked PSA density as not used, whereas the guideline makes it decisive. The guideline suggests that the PI-RADS score and PSA density should be used together to guide the decision. The guideline requires the prior grade of the prior biopsy to be established to determine the next step, which is a fact the panel does not represent.

WHAT THE DOCUMENTS MUST SETTLE
previous_notes - the documented grade of the prior biopsy: at ISUP 2 or above the guideline sends him to treatment, not to more tissue; if it is unrecorded the indication stands
radiology_report - whether the lesion is compared against an earlier study: unchanged does not support re-sampling, new or larger does
psa_trend - the rate of PSA change: this is not explicitly addressed by the retrieved guideline fragment, but the guideline focuses on static risk factors like PI-RADS and PSA-D.
laboratory_results - the PSA density value: this value is used by the guideline to place the patient into a risk category, which is a key factor in the decision.

## Intervención 8 — MODERATOR

*chairs the discussion; sets the open questions and assigns the documents* · vuelta 1

This case hinges entirely on establishing the documented grade of the prior biopsy, as the cohort expert noted that the panel alone is insufficient.

The documents for this session were fixed by EXPERT-TRACE; what I add is the question each one has to answer, and the open questions for the room.

REGISTRAR — pull these up, and answer exactly the question attached to each:
  radiology_report (get_mri_report) -> Whether the lesion is compared against an earlier study.
  psa_trend (get_psa_trend) -> The rate of PSA change.
  previous_notes (get_previous_notes) -> The documented grade of the prior biopsy: at ISUP 2 or above the guideline sends him to treatment, not to more tissue; if it is unrecorded the indication stands.
  laboratory_results (get_lab_results) -> The PSA density value, as this value is used by the guideline to place the patient into a risk category.

OPEN QUESTIONS for this conference — these are what the decision hangs on:
  Q1. What is the documented grade of the prior biopsy?

On the plan itself: Dropped 1 question(s) that asked for a value already printed on the panel: "Does the combination of PI-RADS 5 and PSA density of 0.153 fall into a category that mandates a biopsy?".

## Intervención 9 — REGISTRAR

*the registrar who pulls up documents; reports what they say, nothing else* · vuelta 1

WHAT I FOUND
radiology_report: Subject: Multiparametric MRI Prostate. Comparison: new. LESION: PI-RADS 5 lesion in the right anterior mid-gland.
psa_trend: PSA trend shows a rise from 0.7 (Dec 2023) to 4.6 (Jan 2025), steepest in the last year.
previous_notes: PRIOR GRADE: low-grade disease (from systematic biopsy). BIOPSY SESSIONS: not recorded. SURVEILLANCE: not recorded. TREATMENT: none recorded.
laboratory_results: The PSA density value is 0.153 ng/mL/mL.
previous_notes: The documented grade of the prior biopsy is low-grade disease.

WHAT I DID NOT OPEN
family-history anamnesis, as it was not opened by the trace model and is not required to determine the immediate next step based on the opened documents.

WHAT THIS SUPPORTS
FOR sampling this patient now:
- PI-RADS 5 lesion in the right anterior mid-gland (from radiology_report).
- PSA trend shows a significant rise to 4.6 ng/mL (from psa_trend).
- PSA density of 0.153 ng/mL/mL places him in a risk category according to the EAU guideline (from laboratory_results and EXPERT-EAU).
AGAINST sampling this patient now:
- Prior biopsy finding is low-grade disease (from previous_notes).

WHERE THIS LEANS
LEAN: biopsy

## Intervención 10 — EXPERT-PSA

*Expert 2, PSA projector; the trajectory behind the headline PSA, with a conformal band* · vuelta 1

Expert 2 here — the PSA projector. I read only the serial PSA the registrar opened.

TRAJECTORY: RISING (borderline). Last value 4.60 ng/mL over 5 points spanning 13 months; velocity +3.13 ng/mL per year; doubling time about 5 months.
PROJECTION at 6 months: 7.0 ng/mL, conformal 95% band 2.0-24.2.

Read the band before the point: it is wide by construction, and I only call a direction when the whole
band clears the last value. This does not vote on the biopsy — a rising PSA in a man with a known
diagnosis is the disease behaving as known — it tells the chair how fast the number is moving.

VARIABLES I WEIGHED — in the form's vocabulary, with this man's values (the serial PSA only)
  noted      PSA = 4.6 ng/mL
  not used   prior biopsy, family history, age, DRE, prostate volume, PSA density, csPCa probability, PI-RADS, comorbidity
CONFIDENCE: borderline — the conformal band does not clear the last value

## Intervención 11 — EXPERT-FUSION

*Expert 3, Extra-Trees on panel + laboratory + MRI prose; speaks only on documents that were opened* · vuelta 1

Expert 3 here — the fusion classifier. I read the panel, the mpMRI report and the laboratory panel; nothing from the previous notes or the PSA series.

SUGGESTION: BIOPSY   p(biopsy) = 0.53
  uncertainty  +/- 0.10 epistemic (95% band 0.34-0.72), of which 0.00 comes from values that had to be imputed
  reliability  LOW ('discuss' tier) — out-of-fold it was right 61% of the time over the 31 labelled cases in this tier

VARIABLES I WEIGHED — in the form's vocabulary, with this man's values (panel + the documents that were opened; PI-RADS here means the report's own wording — DWI restriction, lesion size — not the score)
  decisive   prior biopsy = Positive (43% of my signal; from bx_positive, bx_none)
  important  PI-RADS = 5 (22% of my signal; from rad_dwi_restriction, rad_lesion_ge15mm)
  noted      DRE = Normal (5% of my signal; from dre_suspicious) · PSA = 4.6 ng/mL (21% of my signal; from fpsa_lt15, psa_delta_prev) · prostate volume = 30.02 mL (4% of my signal; from log_vol, vol) · PSA density = 0.153 (0% of my signal; from psad_calc) · comorbidity = 1 on the problem list (4% of my signal; from n_comorbidities, on_alpha_blocker)
  not used   family history, age, csPCa probability
CONFIDENCE: uncertain — 'discuss' tier; out-of-fold it was right 61% of the time over the 31 labelled cases in this tier

Out-of-fold AUC 0.794. I am the only expert that has read the report's
wording, and I still cannot see the prior grade or the surveillance history: those are in the notes, and
the registrar has to carry them.

## Intervención 12 — PANEL-PROTOCOL

*the panel's written protocol; consolidates the experts by rule and says which rule fired* · vuelta 1

The panel protocol, applied to what is on the board:

  EXPERT-STRUCTURED  BIOPSY, p(biopsy)=0.57  ('discuss' tier; weight 1.0)
  EXPERT-FUSION      BIOPSY, p(biopsy)=0.53  ('discuss' tier, fusion_full; weight 1.5)
  EXPERT-LIBRARY     BIOPSY, p(biopsy)=1.00  (k=3 precedents; does not vote)

  documented prior grade in the opened documents: none recorded

RULE THAT FIRED: weighted vote of the trained experts, p = 0.54 — carried by weighted panel.
PANEL ANSWER: BIOPSY. EXPERT-FUSION carried the most weight ('discuss' tier, fusion_full). In this bucket no rule applied and the documents did not record the prior grade, so the trained experts decide.

THE BOARD'S VARIABLES — value · what each expert marked · what goes on the form
  bx           Positive                     E1:DEC E3:DEC cohort:IMP library:IMP E2:—            -> important
  fh           not opened (0 of 91)         E1:— E3:— cohort:— library:not E2:—                  -> not_used (raised from noted by the board)
  age          76                           E1:not E3:— cohort:not library:IMP E2:—              -> important
  dre          Normal                       E1:not E3:not cohort:not library:not E2:—            -> noted
  psa          4.6 ng/mL                    E1:not E3:not cohort:not library:IMP E2:not          -> important
  vol          30.02 mL                     E1:not E3:not cohort:not library:not E2:—            -> noted
  psad         0.153                        E1:not E3:not cohort:not library:not E2:—            -> noted
  cspca        0.82                         E1:not E3:— cohort:— library:IMP E2:—                -> not_used
  pirads       5                            E1:not E3:IMP cohort:not library:DEC E2:—            -> important
  comorbidity  1 on the problem list        E1:IMP E3:not cohort:not library:not E2:—            -> noted
  (DEC decisive · IMP important · not noted · — not used; the last column is the level recorded, from the trace of the reading urologist)

Confidence to record: borderline.

CHAIR: this is the panel's position. You sign it, and you write why in the room's words — naming what the registrar retrieved. If you believe a retrieved finding overturns it, name that finding with its value; the burden is on the finding, not on the panel.

## Intervención 13 — VERIFIER

*second EAU reader; checks against the guideline whether this can be decided yet* · vuelta 1

SUFFICIENCY
The documents the registrar opened (radiology_report, psa_trend, previous_notes, laboratory_results) collectively address the moderator's question regarding the prior biopsy grade, as the previous_notes explicitly state the "PRIOR GRADE: low-grade disease (from systematic biopsy)."

ALIGNMENT WITH THE PANEL
The panel protocol concluded BIOPSY based on a weighted vote, noting that the "documented prior grade in the opened documents: none recorded." However, the retrieved information from previous_notes directly contradicts this premise by stating the prior grade was "low-grade disease." This retrieved finding supports the need for further action, aligning with the leaning towards biopsy.

THE OPEN QUESTIONS, ONE BY ONE
Q1. What is the documented grade of the prior biopsy? This question is answered by the registrar's report, which states the "PRIOR GRADE: low-grade disease (from systematic biopsy)."

WHAT CARRIES WEIGHT, AND WHY
prior biopsy: noted / low-grade disease (from previous_notes). I would move this to 'decisive' because the prior biopsy result is the most critical piece of information missing from the panel, and its documented grade directly impacts the decision pathway. The panel's recorded level of 'none recorded' is therefore inaccurate based on the retrieved data. My confidence in the record as it stands is clear, as the necessary information to resolve the primary open question has been retrieved.

MY SUGGESTION TO THE CHAIR
I suggest proceeding with a biopsy, as the documented prior grade of low-grade disease, combined with the PI-RADS 5 and rising PSA trend, indicates that the established surveillance protocol may require escalation based on the EAU guideline's emphasis on prior grade.

VERDICT: ready | SUGGEST: biopsy | MISSING: none

[The conference closes after pass 1: the verifier called the record ready. The chair decides on the record as it stands.]

## Intervención 14 — CHAIR

*the senior urologist who signs the decision* · vuelta 1

MY DECISION: BIOPSY   (confidence: borderline)

76y male, PSA 4.6, PSAD 0.153, PI-RADS 5, prior biopsy positive but grade not recorded. High PI-RADS 5 and new lesion status warrant sampling to determine management. Prior grade is not recorded, which is a key missing fact. Biopsy recommended for definitive staging.

What carried weight: bx=important, age=important, dre=noted, psa=important, vol=noted, psad=noted, pirads=important, comorbidity=noted
Sections retrieved: radiology_report, psa_trend, previous_notes, laboratory_results
